AUG 11, 2016 3:17 PM PDT

Analysis of the Ribozyme Finds a High Tolerance for Mutations

WRITTEN BY: Carmen Leitch
In new research published in the journal Angewandte Chemie, scientists applied a high throughput methodology to study the ribozyme in an innovative way. While work in this area has typically used mutations to study the structure and function of the molecule, this new approach has applied multiple mutations at the same time.  
An image of  ribozymes. / Credit: OIST
Ribozymes were discovered over 30 years ago, and more recently these ribonucleic acid structures have been found in myriad organisms. These molecules have not yet been fully characterized and all its roles are not yet known; they catalyze chemical reactions and are capable of joining amino acids, splicing RNA and replicating viral material. Some researchers have suggested that they performed many of the functions of enzymatic proteins before proteins evolved.

You can find out more about them by watching the video below, featuring Dr. Thomas Cech. He won the Nobel Prize for Chemistry in 1989 with Sidney Altman "for their discovery of catalytic properties of RNA."
Researchers that use mutations to reveal more about the structure and function of ribozymes can only use a few different modifications at any one time with current techniques. With all the different potential combinations of mutations, the selection process is often arbitrary, and such a method can thus miss important areas of the ribozyme sequence that could be critical clues to functionality.

Scientists at the Nucleic Acid Chemistry and Engineering Unit of the Okinawa Institute of Science and Technology Graduate University (OIST), Shungo Kobori and Yohei Yokobayashi, have created a brand new way of studying ribozyme mutants.

"Instead of selecting specific mutations, we decided to make and test as many mutants as possible of a specific ribozyme," explained Yokobayashi. A ribozyme with only one different base from the original ribozyme sequence is a single mutant. A double mutant has two bases that are different from the original. For even the smallest ribozyme studied by the researchers, only 48 bases, there are 10,296 total single and double mutants.
An image of the 3-D structure of a ribozyme. CREDIT OIST
"With the help of a powerful DNA sequencer at OIST, we generated and then measured the chemical activity of all the single and double mutants of a variant of the 'twister ribozyme', which is found in the genome of rice," said Yokobayashi. "Thanks to this comprehensive approach, we now have a better understanding of which bases are more important for this ribozyme activity."

One particularly interesting finding is that the ribozyme is very tolerant to mutations. "This result is surprising," Yokobayashi said, "because the ribozyme we studied has a quite compact and complex structure." While much of the sequence likely helps to maintain the structure of the ribozyme, a significant portion of the mutants still had ribozyme activity. 

The retention of enzymatic ability in the face of mutation might have been an evolutionary advantage, and may explain why ribozymes are so widespread among different forms of life.

Because ribozymes can control gene expression in both live cells and viruses, a better understanding of how they work could lead to improvements in their therapeutic applications.

Sources: Biologist, NobelPrize.orgAngewandte Chemie, AAAS/Eurekalert! via OIST

 
About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 23, 2022
Microbiology
Heme-Loving Plant Peptide Could Have Many Applications
SEP 23, 2022
Heme-Loving Plant Peptide Could Have Many Applications
Symbiotic relationships enable organisms to use one another, usually to the advantage of both. Legumes can live in symbi ...
SEP 30, 2022
Coronavirus
A New Kind of Antiviral Against SARS-CoV-2
SEP 30, 2022
A New Kind of Antiviral Against SARS-CoV-2
Scientists are developing a human version of a drug that was highly beneficial to a hamster model of COVID-19. The drug, ...
NOV 11, 2022
Immunology
Regenerating the Immune System to Halt Multiple Sclerosis
NOV 11, 2022
Regenerating the Immune System to Halt Multiple Sclerosis
A bone marrow or blood stem cell transplant has been an effective but risky way to treat multiple sclerosis (MS), and no ...
NOV 15, 2022
Genetics & Genomics
Revealing the Mutations that Make Melanoma Immortal
NOV 15, 2022
Revealing the Mutations that Make Melanoma Immortal
Telomeres cap the ends of chromosomes, preventing breakage. Some cancer cells can use those protective caps to their adv ...
NOV 26, 2022
Neuroscience
A Crucial Enzyme Seems to Switch Off Randomly, Defying Previous Expectations
NOV 26, 2022
A Crucial Enzyme Seems to Switch Off Randomly, Defying Previous Expectations
A crucial enzyme in the mammalian brain seems to randomly switch on and off, according to new research reported in Natur ...
NOV 28, 2022
Neuroscience
Experimental Drug Halts Deadly Brain Cancer Growth Without Harming Brain Cells
NOV 28, 2022
Experimental Drug Halts Deadly Brain Cancer Growth Without Harming Brain Cells
  Researchers have found that blocking a certain enzyme halts the growth of a childhood brain cancer tumor. The cor ...
Loading Comments...